Vanguard Group’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $62.8K | Hold |
|
|||||
|
2023
Q4 | $65.2K | Sell |
|
|||||
|
2023
Q3 | $185K | Sell |
|
|||||
|
2023
Q2 | $4.46M | Buy |
|
|||||
|
2023
Q1 | $2.73M | Buy |
|
|||||
|
2022
Q4 | $774K | Buy |
|
|||||
|
2022
Q3 | $755K | Sell |
|
|||||
|
2022
Q2 | $567K | Sell |
|
|||||
|
2022
Q1 | $1.04M | Sell |
|
|||||
|
2021
Q4 | $2.15M | Sell |
|
|||||
|
2021
Q3 | $3.9M | Hold |
|
|||||
|
2021
Q2 | $4.73M | Sell |
|
|||||
|
2021
Q1 | $4.47M | Buy |
|
|||||
|
2020
Q4 | $5.13M | Buy |
|
|||||
|
2020
Q3 | $3.32M | Sell |
|
|||||
|
2020
Q2 | $2.63M | Buy |
|
|||||
|
2020
Q1 | $1.52M | Buy |
|
|||||
|
2019
Q4 | $997K | Buy |
|